Institutional investors purchased a net $2.0 million shares of NSPR during the quarter ended December 2012. This may signal that the smart money is gaining interest in this company as the 12.84% of shares outstanding that institutional investors hold is actually below the Medical Specialties industry average.
| Individual stakeholders | 18.59% |
| Other institutional | 12.83% |
| Mutual fund holders | 0.01% |